Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Paraventricular Hypothalamic Nucleus | 2 | 2018 | 9 | 1.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2018 | 40 | 1.020 |
Why?
|
| Heart Rate | 3 | 2020 | 372 | 0.760 |
Why?
|
| Autonomic Nervous System | 1 | 2020 | 51 | 0.620 |
Why?
|
| Amyloidosis | 1 | 2019 | 17 | 0.580 |
Why?
|
| Heart | 1 | 2020 | 191 | 0.580 |
Why?
|
| Receptor, trkB | 1 | 2018 | 3 | 0.560 |
Why?
|
| Cognition | 2 | 2024 | 576 | 0.510 |
Why?
|
| Stress, Psychological | 1 | 2018 | 233 | 0.480 |
Why?
|
| Angiotensin II | 2 | 2024 | 244 | 0.480 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 295 | 0.460 |
Why?
|
| Solitary Nucleus | 1 | 2015 | 34 | 0.450 |
Why?
|
| Endocannabinoids | 1 | 2015 | 43 | 0.440 |
Why?
|
| Baroreflex | 1 | 2015 | 86 | 0.430 |
Why?
|
| Heart Failure | 1 | 2019 | 780 | 0.360 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2018 | 923 | 0.310 |
Why?
|
| Aging | 1 | 2015 | 1010 | 0.280 |
Why?
|
| Renin | 2 | 2024 | 109 | 0.260 |
Why?
|
| Sepsis | 2 | 2024 | 167 | 0.230 |
Why?
|
| Angiotensinogen | 1 | 2024 | 59 | 0.210 |
Why?
|
| Lactic Acid | 1 | 2024 | 59 | 0.210 |
Why?
|
| Age Factors | 2 | 2020 | 1262 | 0.210 |
Why?
|
| Retinal Artery | 1 | 2024 | 6 | 0.210 |
Why?
|
| Shock, Septic | 1 | 2024 | 26 | 0.210 |
Why?
|
| Critical Illness | 1 | 2024 | 89 | 0.200 |
Why?
|
| Male | 6 | 2024 | 20739 | 0.180 |
Why?
|
| Blood Pressure | 2 | 2016 | 901 | 0.170 |
Why?
|
| Vasoconstrictor Agents | 2 | 2024 | 65 | 0.170 |
Why?
|
| Animals | 3 | 2018 | 8578 | 0.160 |
Why?
|
| Prealbumin | 1 | 2019 | 9 | 0.150 |
Why?
|
| Mental Health | 1 | 2020 | 126 | 0.150 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 372 | 0.140 |
Why?
|
| Rats, Transgenic | 1 | 2018 | 48 | 0.140 |
Why?
|
| Memory | 1 | 2020 | 216 | 0.140 |
Why?
|
| Eating | 1 | 2018 | 81 | 0.130 |
Why?
|
| Atherosclerosis | 1 | 2024 | 837 | 0.130 |
Why?
|
| Health Status | 1 | 2020 | 411 | 0.130 |
Why?
|
| Sympathetic Nervous System | 1 | 2016 | 34 | 0.120 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2016 | 64 | 0.120 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2016 | 70 | 0.120 |
Why?
|
| Cardiovascular System | 1 | 2016 | 51 | 0.120 |
Why?
|
| Prognosis | 1 | 2020 | 1606 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1607 | 0.120 |
Why?
|
| Glycerides | 1 | 2015 | 14 | 0.110 |
Why?
|
| Electrocardiography | 1 | 2020 | 657 | 0.110 |
Why?
|
| Arachidonic Acids | 1 | 2015 | 28 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 138 | 0.110 |
Why?
|
| Microinjections | 1 | 2015 | 39 | 0.110 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2015 | 23 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 114 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2015 | 81 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 281 | 0.110 |
Why?
|
| Time Factors | 1 | 2020 | 2353 | 0.110 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2015 | 68 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2020 | 2463 | 0.110 |
Why?
|
| Piperidines | 1 | 2015 | 141 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2018 | 771 | 0.100 |
Why?
|
| Humans | 5 | 2024 | 34562 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2015 | 545 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 526 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 4157 | 0.090 |
Why?
|
| Brain | 1 | 2019 | 1031 | 0.090 |
Why?
|
| United States | 1 | 2020 | 4278 | 0.090 |
Why?
|
| Aged | 2 | 2024 | 11022 | 0.080 |
Why?
|
| Middle Aged | 2 | 2024 | 12726 | 0.080 |
Why?
|
| Female | 3 | 2024 | 21531 | 0.080 |
Why?
|
| Hypertension | 1 | 2016 | 1024 | 0.070 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2024 | 6 | 0.050 |
Why?
|
| Retinal Vessels | 1 | 2024 | 27 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2024 | 120 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2024 | 103 | 0.050 |
Why?
|
| Retina | 1 | 2024 | 86 | 0.050 |
Why?
|
| Renin-Angiotensin System | 1 | 2024 | 178 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 565 | 0.040 |
Why?
|
| Risk Factors | 1 | 2024 | 4137 | 0.030 |
Why?
|